Literature DB >> 16216812

Spatial distribution of mast cells in chronic venous leg ulcers.

S A Abd-El-Aleem1, C Morgan, M W J Ferguson, C N McCollum, G W Ireland.   

Abstract

Chronic venous leg ulcers (CVUs) show chronic inflammation but different pathological changes occur in different parts of the ulcer. There is a lack of re-epithelialisation and defective matrix deposition in the ulcer base but epidermal hyperproliferation and increased matrix deposition in the surrounding skin. The role of mast cells in wound healing, inflammation, fibrosis and epidermal hyperproliferation has been extensively studied but less is known about their role in CVUs. In the present study, we investigated the distribution of mast cells in CVUs with specific consideration of the differences between the ulcer base and the skin surrounding the ulcer. Both histochemical and immunohistological methods were used to detect the mast cell marker tryptase in frozen sections of CVU biopsies. Mast cells were counted in the dermis of normal skin, in the ulcer base and in the skin surrounding the ulcer. Double immunofluorescence staining was used to study the location of mast cells in relation to blood vessels. In normal skin few mast cells were seen in the dermis but none in the epidermis. However in CVUs there was a significant increase in intact and degranulated mast cells in the surrounding skin and ulcer edge (184 per field, p<0.003) of CVUs and a significant reduction in the ulcer base (20.5 per field p<0.05) in comparison to normal skin (61 per field). In CVUs mast cells showed a characteristic location near the epithelial basement membrane whilst mast cell granules and phantom cells (mast cells devoid of granules) were predominantly seen in the epidermis. In the dermis, mast cells were seen associated with blood vessels. The marked increase in mast cells in the surrounding skin of CVUs and depletion of mast cells in the ulcer base could implicate mast cell mediators in the pathological changes in CVUs particularly in the epidermal and vascular changes occurring in the surrounding skin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16216812

Source DB:  PubMed          Journal:  Eur J Histochem        ISSN: 1121-760X            Impact factor:   3.188


  6 in total

Review 1.  Mast cell activity in the healing wound: more than meets the eye?

Authors:  Brian C Wulff; Traci A Wilgus
Journal:  Exp Dermatol       Date:  2013-06-27       Impact factor: 3.960

2.  Effects of a new nutraceutical substance on clinical and molecular parameters in patients with chronic venous ulceration.

Authors:  Raffaele Serra; Raffaele Grande; Lucia Butrico; Gianluca Buffone; Francesco G Caliò; Aida Squillace; Barbara A Rizzo; Mafalda Massara; Francesco Spinelli; Alessia G Ferrarese; Giovanni de Caridi; Luca Gallelli; Stefano de Franciscis
Journal:  Int Wound J       Date:  2014-02-25       Impact factor: 3.315

3.  Arachidonic acid-derived signaling lipids and functions in impaired healing.

Authors:  Sandeep Dhall; Dayanjan Shanaka Wijesinghe; Zubair A Karim; Anthony Castro; Hari Priya Vemana; Fadi T Khasawneh; Charles E Chalfant; Manuela Martins-Green
Journal:  Wound Repair Regen       Date:  2015-09-14       Impact factor: 3.617

4.  The use of growth factors, CD34(+) cells and fibrin for the management of chronic venous ulcers.

Authors:  Francesco Romano; Francesco M Paolino; Barbara A Rizzo; Antonio Russo; Stephen Southworth; Raffaele Serra; Luca Gallelli
Journal:  Int Wound J       Date:  2015-09-15       Impact factor: 3.315

Review 5.  Harnessing the Power of Mast Cells in unconventional Immunotherapy Strategies and Vaccine Adjuvants.

Authors:  Steven Willows; Marianna Kulka
Journal:  Cells       Date:  2020-12-18       Impact factor: 6.600

6.  Mast cells and the liver aging process.

Authors:  Fabio Grizzi; Maurizio Chiriva-Internati; Giuseppe Di Caro; Luigi Laghi; Paul Hermonat; Paolo Mazzola; Diane D Nguyen; Saba Radhi; Jose A Figueroa; Everardo Cobos; Giorgio Annoni
Journal:  Immun Ageing       Date:  2013-03-07       Impact factor: 6.400

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.